MENUDlugosz to oversee basic science research at Rogel Cancer Center
Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine, 800-865-1125
ANN ARBOR, Michigan — The University of Michigan Rogel Cancer Center has named Andrzej Dlugosz, M.D., associate director for basic science research.
Dlugosz is the Poth Professor of Cutaneous Oncology and professor of dermatology and of cell and developmental biology at the University of Michigan. He currently co-leads the Rogel Cancer Center’s cancer biology program.
In his new role, Dlugosz will oversee the Rogel Cancer Center’s four basic science research programs, which focus on cancer biology, genetics, developmental therapeutics and immunology.
“Anj has demonstrated leadership and commitment to the Rogel Cancer Center over many years, and in his new role will work toward facilitating team-based science across multiple programs. He will be an outstanding member of the center’s senior leadership team, and I look forward to seeing our basic science programs continue to grow and excel under his direction,” says Eric Fearon, M.D., Ph.D., director of the Rogel Cancer Center.
Dlugosz earned his medical degree from Pennsylvania State University College of Medicine and trained at the University of Pennsylvania and the National Cancer Institute. He joined the faculty at the University of Michigan in 1997 and currently serves as associate chair for research in the Department of Dermatology.
His research focuses on how alterations in the Hedgehog signaling pathway contribute to cancer initiation, progression and maintenance in tumors arising in the skin and other organs. In more recent studies, he has also been investigating the molecular underpinnings of Merkel cell carcinoma, an aggressive neuroendocrine skin cancer.
Dlugosz has received numerous honors and awards, including election to the American Society for Clinical Investigation and the Association of American Physicians.
Dlugosz replaces Stephen Weiss, M.D., who stepped down to build on his laboratory research efforts. Dlugosz’ appointment is effective Nov. 1.